Innate Pharma Halts Phase 1b Trial for Peripheral T Cell Lymphoma Treatment Amidst NextCure Layoff Announcement

talkbio0Tagged , , ,

1. Innate Pharma has decided to end its Phase 1b clinical trial for a cancer drug targeting peripheral T cell lymphoma.
2. This development coincides with layoffs announced by NextCure, another biopharmaceutical company.
3. Additional industry news includes updates from companies like Evommune, Maruho, and Nouscom.

Leave a Reply

Your email address will not be published. Required fields are marked *